Yubo International Biotech Limited (YBGJ)
OTCMKTS · Delayed Price · Currency is USD
0.1000
+0.0100 (11.11%)
Jul 16, 2025, 3:11 PM EDT

YBGJ Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
114361149-
Upgrade
Market Cap Growth
-95.01%-88.45%215.79%-76.90%--
Upgrade
Enterprise Value
145361352-
Upgrade
Last Close Price
0.090.030.300.100.42-
Upgrade
PS Ratio
-601766.611196.5559.45109.1639.60-
Upgrade
PB Ratio
-2.97-1.26-19.50-20.13-375.59-
Upgrade
EV/Sales Ratio
-1450.9160.25129.4341.43-
Upgrade
Debt / Equity Ratio
-1.00-0.21-0.21-1.40-20.530.27
Upgrade
Debt / FCF Ratio
-----5.38
Upgrade
Asset Turnover
-0.000.300.030.350.76
Upgrade
Inventory Turnover
1.701.690.690.213.66-
Upgrade
Quick Ratio
0.090.100.110.140.211.42
Upgrade
Current Ratio
0.140.140.210.300.381.49
Upgrade
Return on Equity (ROE)
-----297.65%-85.95%
Upgrade
Return on Assets (ROA)
-93.88%-77.36%-37.19%-21.72%-27.43%-24.90%
Upgrade
Return on Capital (ROIC)
----54.04%-47.67%-35.34%
Upgrade
Earnings Yield
-16.93%-42.76%-3.33%-10.59%-3.13%-
Upgrade
FCF Yield
-12.80%-32.22%-2.06%-5.28%-3.22%-
Upgrade
Buyback Yield / Dilution
-22.50%-900.00%89.91%-0.50%-1.94%-1058.84%
Upgrade
Updated Nov 13, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.